Cargando…

Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery

In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome variou...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Abhinav P., Chandra, Suresh, Tiwari, Ruchi, Srivastava, Ashish, Tiwari, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210501/
https://www.ncbi.nlm.nih.gov/pubmed/30505359
http://dx.doi.org/10.2174/1874104501812010111
_version_ 1783367129663275008
author Mishra, Abhinav P.
Chandra, Suresh
Tiwari, Ruchi
Srivastava, Ashish
Tiwari, Gaurav
author_facet Mishra, Abhinav P.
Chandra, Suresh
Tiwari, Ruchi
Srivastava, Ashish
Tiwari, Gaurav
author_sort Mishra, Abhinav P.
collection PubMed
description In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting.
format Online
Article
Text
id pubmed-6210501
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-62105012018-11-30 Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery Mishra, Abhinav P. Chandra, Suresh Tiwari, Ruchi Srivastava, Ashish Tiwari, Gaurav Open Med Chem J Medicinal Chemistry In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting. Bentham Open 2018-10-23 /pmc/articles/PMC6210501/ /pubmed/30505359 http://dx.doi.org/10.2174/1874104501812010111 Text en © 2018 Mishra et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4. 0 International Public License (CC-BY 4. 0), a copy of which is available at: https://creativecommons. org/licenses/by/4. 0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Medicinal Chemistry
Mishra, Abhinav P.
Chandra, Suresh
Tiwari, Ruchi
Srivastava, Ashish
Tiwari, Gaurav
Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title_full Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title_fullStr Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title_full_unstemmed Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title_short Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
title_sort therapeutic potential of prodrugs towards targeted drug delivery
topic Medicinal Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210501/
https://www.ncbi.nlm.nih.gov/pubmed/30505359
http://dx.doi.org/10.2174/1874104501812010111
work_keys_str_mv AT mishraabhinavp therapeuticpotentialofprodrugstowardstargeteddrugdelivery
AT chandrasuresh therapeuticpotentialofprodrugstowardstargeteddrugdelivery
AT tiwariruchi therapeuticpotentialofprodrugstowardstargeteddrugdelivery
AT srivastavaashish therapeuticpotentialofprodrugstowardstargeteddrugdelivery
AT tiwarigaurav therapeuticpotentialofprodrugstowardstargeteddrugdelivery